Survival comparisons between populations or population groups (using funnel plots)

Size: px
Start display at page:

Download "Survival comparisons between populations or population groups (using funnel plots)"

Transcription

1 Survival comparisons between populations or population groups (using funnel plots) Manuela Quaresma Cancer Research UK Cancer Survival Group London School of Hygiene and Tropical Medicine EPAAC WP9 Satellite Meeting Ispra, January 2014

2 Important points to consider for a fair comparison a priori of survival estimation: Data collection: a common protocol Centralised quality control of data Strict control of background mortality Standardised analytic techniques, including software Age-standardisation of estimates a posteriori of survival estimation: Use funnel plots for survival comparisons Survival comparisons between populations or population groups Ispra, January /12

3 Funnel plots for survival / excess hazard comparisons between populations Survival comparisons between populations or population groups Ispra, January /12

4 Funnel plots for survival / excess hazard comparisons between populations Survival comparisons between populations or population groups Ispra, January /12

5 Example 1: USA component of cancer survival in five continents (CONCORD) Coleman et al, Lancet Oncology 2008 Adults diagnosed and followed up to 31 December 1999 Relative survival up to five years Background mortality: sex, single year age, calendar year, geographic area, race (black, white) Age-standardised: International Cancer Survival Standard (ICSS) Survival comparisons between populations or population groups Ispra, January /12

6 Example 1: Area-specific survival by race and cancer registration system Survival comparisons between populations or population groups Ispra, January /12

7 Example 2: Index of cancer survival by Clinical Commissioning Groups (CCG) Quaresma et al, Office for National Statistics, 2013 CCGs: responsible for health-commissioning in England All adults diagnosed , follow-up December 2012 Net survival using flexible parametric regression models Age-cancer-sex standardised Survival comparisons between populations or population groups Ispra, January /12

8 Example 2: Index of one-year net survival by CCGs Survival comparisons between populations or population groups Ispra, January /12

9 Example 3: Regional differences in cancer survival, Japan Ito Y et al, Cancer Science 2009 Wide differences in 5-year relative survival between 6 prefectures in Japan Aim: To determine how much age and stage at diagnosis could explain the differences in survival Regression models for relative survival (Poisson): successive adjustments: (follow-up time, region) + (age) + (stage) inclusion contrast: compare excess hazards for each region with excess hazard averaged for all regions combined Survival comparisons between populations or population groups Ispra, January /12

10 Example 3: Excess hazard of death by prefecture: stomach cancer, men Survival comparisons between populations or population groups Ispra, January /12

11 Potential difficulties: Over-dispersion and precision Overdispersion More variability than expected Insufficient risk adjustment? Over-dispersion factor: Winsorising Random-effects model Precision Interpretation - not as intuitive as sample size (N)? Loss in precision with successive adjustments? Wide range in precision: large vs small regions Survival comparisons between populations or population groups Ispra, January /12

12 References Spiegelhalter, DJ. Funnel plots for comparing institutional performance. Stat.Med., 2005 Spiegelhalter, DJ. Handling over-dispersion of performance indicators. Quality Safety Health Care, 2005 Quaresma, M. et al. Funnel plots for population-based cancer survival: principles, methods and applications. Stat.Med., 2013 Command Funnel plot for cancer survival - R and STATA software (to be available in 2014) Survival comparisons between populations or population groups Ispra, January /12

Downloaded from:

Downloaded from: Morris, M. ; Quaresma, M. ; Pitkniemi, J. ; Morris, E. ; Rachet, B. ; Coleman, M.P. (2016) [Accepted Manuscript] Do cancer survival statistics for every hospital make sense? The lancet oncology. ISSN 1470-2045

More information

Data visualisation: funnel plots and maps for small-area cancer survival

Data visualisation: funnel plots and maps for small-area cancer survival Cancer Outcomes Conference 2013 Brighton, 12 June 2013 Data visualisation: funnel plots and maps for small-area cancer survival Manuela Quaresma Improving health worldwide www.lshtm.ac.uk Background Describing

More information

Downloaded from:

Downloaded from: Coleman, MP; Quaresma, M; Butler, J; Rachet, B (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK Reply. Lancet, 377 (9772). pp. 1149-1150. ISSN 0140-6736 Downloaded from:

More information

Ovarian Cancer Prevalence:

Ovarian Cancer Prevalence: Ovarian Cancer Prevalence: Basic Information 1. What is being measured? 2. Why is it being measured? The prevalence of ovarian cancer, ICD-10 C56 Prevalence is an indicator of the burden of cancer and

More information

THE ISSUE OF STAGE AT DIAGNOSIS

THE ISSUE OF STAGE AT DIAGNOSIS THE ISSUE OF STAGE AT DIAGNOSIS IN SURVIVAL ANALYSIS Pamela Minicozzi Analytical Epidemiology and Health Impact Unit Department of Preventive and Predictive Medicine, Fodazione IRCCS Istituto Nazionale

More information

Age-standardised Net Survival & Cohort and Period Net Survival Estimates

Age-standardised Net Survival & Cohort and Period Net Survival Estimates Cancer survival analysis using population-based data Granada, 27-28 March 2017 Age-standardised Net Survival & Cohort and Period Net Survival Estimates Cancer survival analysis using population-based data

More information

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England Population-based cancer survival trends in England and Wales up to 7: an assessment of the NHS cancer plan for England Bernard Rachet, Camille Maringe, Ula Nur, Manuela Quaresma, Anjali Shah, Laura M Woods,

More information

Deprivation and Cancer Survival in Scotland: Technical Report

Deprivation and Cancer Survival in Scotland: Technical Report Deprivation and Cancer Survival in Scotland: Technical Report 1 Foreword We are delighted to publish the first report from the Macmillan Cancer Support partnership with the Information Services Division.

More information

Technical Briefing 2. Statistical process control methods in public health intelligence. Purpose

Technical Briefing 2. Statistical process control methods in public health intelligence. Purpose Technical Briefing 2 December 2007 - Issue 2 Statistical process control methods in public health intelligence All things have their own measure; ultimately there are fixed limits outside which something

More information

Downloaded from:

Downloaded from: Rachet, B; Coleman, MP; Ellis, L; Shah, A; Cooper, N; Rasulo, D; Westlake, S (8) Cancer survival in the Primary Care Trusts of England, 1998-4. Technical Report. Office for National Statistics. Downloaded

More information

Beyond RevMan: Meta-Regression. Analysis in Context

Beyond RevMan: Meta-Regression. Analysis in Context Beyond RevMan: Meta-Regression Analysis in Context Robin Christensen, MSc, Biostatistician The Parker Institute: Musculoskeletal Statistics Unit Frederiksberg Hospital Copenhagen, Denmark Statistical Editor

More information

Estimating relative survival using the strel command

Estimating relative survival using the strel command Estimating relative survival using the strel command Bernard Rachet 7 September 2007 Stata workshop - Stockholm 1 Basis concepts Estimation of disease-specific lethality in a group of cancer patients.

More information

Cervical Cancer Surgery:

Cervical Cancer Surgery: Cervical Cancer Surgery: Basic Information 1. What is being measured? 2. Why is it being measured? 3. How is the indicator defined? The proportion of cervical cancer patients who received surgery. Surgery

More information

RESEARCH ARTICLE. Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry

RESEARCH ARTICLE. Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry DOI:http://dx.doi.org/.734/APJCP.22.3..568 RESEARCH ARTICLE Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry Mai Utada *, Yuko

More information

7/11/2011. The impact of cancer survival studies on health policy. NCI prevention budget falls. Cases Deaths Survivors

7/11/2011. The impact of cancer survival studies on health policy. NCI prevention budget falls. Cases Deaths Survivors The impact of cancer survival studies on health policy North American Association of Central Cancer Registries Louisville KY, 21 June 2011 NCI prevention budget falls Cancer burden set to rise Cases Deaths

More information

Treatment effect estimates adjusted for small-study effects via a limit meta-analysis

Treatment effect estimates adjusted for small-study effects via a limit meta-analysis Treatment effect estimates adjusted for small-study effects via a limit meta-analysis Gerta Rücker 1, James Carpenter 12, Guido Schwarzer 1 1 Institute of Medical Biometry and Medical Informatics, University

More information

Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, : population based study

Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, : population based study Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study Aimilia Exarchakou, Bernard Rachet, Aurélien Belot, Camille Maringe,

More information

M. J. Rutherford 1,*, T. M-L. Andersson 2, H. Møller 3, P.C. Lambert 1,2.

M. J. Rutherford 1,*, T. M-L. Andersson 2, H. Møller 3, P.C. Lambert 1,2. Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: avoidable deaths and potential gain in expectation of life. M. J. Rutherford 1,*, T. M-L. Andersson

More information

Investigation of relative survival from colorectal cancer between NHS organisations

Investigation of relative survival from colorectal cancer between NHS organisations School Cancer of Epidemiology something Group FACULTY OF OTHER MEDICINE AND HEALTH Investigation of relative survival from colorectal cancer between NHS organisations Katie Harris k.harris@leeds.ac.uk

More information

On-going and planned colorectal cancer clinical outcome analyses

On-going and planned colorectal cancer clinical outcome analyses On-going and planned colorectal cancer clinical outcome analyses Eva Morris Cancer Research UK Bobby Moore Career Development Fellow National Cancer Data Repository Numerous routine health data sources

More information

Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer

Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer Jason D. Wright, MD, Yongemei Huang, MD/PhD, William M. Burke, MD, et al. Journal Club March 16, 2016 Blaine Campbell-PGY2 Objective

More information

Causal mediation analysis of observational, population-based cancer survival data

Causal mediation analysis of observational, population-based cancer survival data Causal mediation analysis of observational, population-based cancer survival data Bernard Rachet & Ruoran Li Cancer Survival Group, Faculty of Epidemiology and Population Health, LSHTM Twitter: @CSG_LSHTM

More information

Nation nal Cancer Institute. Prevalence Projections: The US Experience

Nation nal Cancer Institute. Prevalence Projections: The US Experience Nation nal Cancer Institute Prevalence Projections: The US Experience State of Art Methods for the Analysis of Population- Based Cancer Data January 22-23, 2014 Ispra, Italy U.S. DEPARTMENT OF HEALTH AND

More information

Module 14: Missing Data Concepts

Module 14: Missing Data Concepts Module 14: Missing Data Concepts Jonathan Bartlett & James Carpenter London School of Hygiene & Tropical Medicine Supported by ESRC grant RES 189-25-0103 and MRC grant G0900724 Pre-requisites Module 3

More information

C2 Training: August 2010

C2 Training: August 2010 C2 Training: August 2010 Introduction to meta-analysis The Campbell Collaboration www.campbellcollaboration.org Pooled effect sizes Average across studies Calculated using inverse variance weights Studies

More information

Is cancer a chronic disease? Prof. Dace Baltina Riga East University Hospital Ministry of Health

Is cancer a chronic disease? Prof. Dace Baltina Riga East University Hospital Ministry of Health Is cancer a chronic disease? Prof. Dace Baltina Riga East University Hospital Ministry of Health Cancer survival statistics 50% of adult cancer patients diagnosed in 2010-2011 in England and Wales are

More information

Cancer Incidence Predictions (Finnish Experience)

Cancer Incidence Predictions (Finnish Experience) Cancer Incidence Predictions (Finnish Experience) Tadeusz Dyba Joint Research Center EPAAC Workshop, January 22-23 2014, Ispra Rational for making cancer incidence predictions Administrative: to plan the

More information

Biostatistics II

Biostatistics II Biostatistics II 514-5509 Course Description: Modern multivariable statistical analysis based on the concept of generalized linear models. Includes linear, logistic, and Poisson regression, survival analysis,

More information

Inequalities in cancer survival: Spearhead Primary Care Trusts are appropriate geographic units of analyses

Inequalities in cancer survival: Spearhead Primary Care Trusts are appropriate geographic units of analyses Inequalities in cancer survival: Spearhead Primary Care Trusts are appropriate geographic units of analyses Libby Ellis* 1, Michel P Coleman London School of Hygiene and Tropical Medicine *Corresponding

More information

Trends in Cure Fraction from Colorectal Cancer by Age and Tumour Stage Between 1975 and 2000, Using Population-based Data, Osaka, Japan

Trends in Cure Fraction from Colorectal Cancer by Age and Tumour Stage Between 1975 and 2000, Using Population-based Data, Osaka, Japan Epidemiology Note Jpn J Clin Oncol 2012;42(10)974 983 doi:10.1093/jjco/hys132 Advance Access Publication 5 September 2012 Trends in Cure Fraction from Colorectal Cancer by Age and Tumour Stage Between

More information

National Bowel Cancer Audit Supplementary Report 2011

National Bowel Cancer Audit Supplementary Report 2011 National Bowel Cancer Audit Supplementary Report 2011 This Supplementary Report contains data from the 2009/2010 reporting period which covers patients in England with a diagnosis date from 1 August 2009

More information

Gastro-oesophageal junction cancers (ICD10 C15.2, C15.5, C16.0) 1

Gastro-oesophageal junction cancers (ICD10 C15.2, C15.5, C16.0) 1 Gastro-oesophageal junction cancers (ICD10 C15., C15.5, C16.0) 1 In England cancers of the gastro-oesophageal junction account for 0% of all cancers arising in the upper gastro-intestinal tract and are

More information

CONCORD Programme: Worldwide Surveillance of Cancer Survival. The US Perspective

CONCORD Programme: Worldwide Surveillance of Cancer Survival. The US Perspective CONCORD Programme: Worldwide Surveillance of Cancer Survival The US Perspective Hannah K Weir, PhD Division of Cancer Prevention and Control Centers for Disease Control and Prevention Overview Cancer Surveillance

More information

Estimating and modelling relative survival

Estimating and modelling relative survival Estimating and modelling relative survival Paul W. Dickman Department of Medical Epidemiology and Biostatistics Karolinska Institutet, Stockholm, Sweden paul.dickman@ki.se Regstat 2009 Workshop on Statistical

More information

National Cancer Patient Experience Survey 2016 Technical Documentation July 2017

National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 1 Contents 1. Introduction 2. Scoring 3. Significance Tests (for national data) 4. Case-mix Adjustment (for local data)

More information

National Lung Cancer Audit outlier policy 2017

National Lung Cancer Audit outlier policy 2017 National Lung Cancer Audit outlier policy 2017 The National Lung Cancer Audit (NLCA) publishes detailed information on the treatment of lung cancer patients, including the outcome of that treatment. Data

More information

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis

More information

Modelled prevalence. Marc COLONNA. January 22-23, 2014 Ispra

Modelled prevalence. Marc COLONNA. January 22-23, 2014 Ispra STATE OF ART OF METHODS FOR THE ANALYSIS OF POPULATION-BASED CANCER DATA : Session 4 :PREVALENCE Modelled prevalence Marc COLONNA Isere Cancer Registry FRANCIM network (France) January 22-23, 2014 Ispra

More information

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior

More information

Cost-effective commissioning of colorectal cancer care: An assessment of the cost-effectiveness of improving early diagnosis

Cost-effective commissioning of colorectal cancer care: An assessment of the cost-effectiveness of improving early diagnosis Cost-effective commissioning of colorectal cancer care: An assessment of the cost-effectiveness of improving early diagnosis London Public Health Knowledge & Intelligence Network 31 January 2017 Panos

More information

MEASURING CANCER CURE IN IRELAND

MEASURING CANCER CURE IN IRELAND MEASURING CANCER CURE IN IRELAND 2019 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised rate (European standard population) IARC International Agency for Research

More information

Impact of cancer symptom awareness campaigns on diagnostic testing and treatment

Impact of cancer symptom awareness campaigns on diagnostic testing and treatment Impact of cancer symptom awareness campaigns on diagnostic testing and treatment Abigail Bentley, Erika Denton, Lucy Ironmonger, Sean Duffy September 2014 Content Background Methods Key results Discussion

More information

Methodology for the Survival Estimates

Methodology for the Survival Estimates Methodology for the Survival Estimates Inclusion/Exclusion Criteria Cancer cases are classified according to the International Classification of Diseases for Oncology - Third Edition (ICDO-3) Disease sites

More information

Promoting Innovative Practice

Promoting Innovative Practice Promoting Innovative Practice Development of centralised care in advanced pancreatic cancer 1 Dr Olosula O Faluyi, Consultant in Medical Oncology and Dr Daniel H Palmer, Chair in Medical Oncology, Clatterbridge

More information

Biostatistics for Med Students. Lecture 1

Biostatistics for Med Students. Lecture 1 Biostatistics for Med Students Lecture 1 John J. Chen, Ph.D. Professor & Director of Biostatistics Core UH JABSOM JABSOM MD7 February 14, 2018 Lecture note: http://biostat.jabsom.hawaii.edu/education/training.html

More information

Cancer survival by stage at diagnosis in Wales,

Cancer survival by stage at diagnosis in Wales, Cancer survival by stage at diagnosis in Wales, 2011-2014 Welsh Cancer Intelligence and Surveillance Unit www.wcisu.wales.nhs.uk Latest available one-year net cancer survival by stage at diagnosis official

More information

UNIVAC decision support model A universal framework for evaluating vaccine policy options in low- and middle-income countries

UNIVAC decision support model A universal framework for evaluating vaccine policy options in low- and middle-income countries UNIVAC decision support model A universal framework for evaluating vaccine policy options in low- and middle-income countries Andrew Clark, London School of Hygiene and Tropical Medicine Key questions

More information

Sample-size re-estimation in Multiple Sclerosis trials

Sample-size re-estimation in Multiple Sclerosis trials Novartis Basel, Switzerland Sample-size re-estimation in Multiple Sclerosis trials Heinz Schmidli PSI Meeting on Sample Size Re-Estimation London, November 2, 2016 Outline Multiple Sclerosis Sample size

More information

Review of Veterinary Epidemiologic Research by Dohoo, Martin, and Stryhn

Review of Veterinary Epidemiologic Research by Dohoo, Martin, and Stryhn The Stata Journal (2004) 4, Number 1, pp. 89 92 Review of Veterinary Epidemiologic Research by Dohoo, Martin, and Stryhn Laurent Audigé AO Foundation laurent.audige@aofoundation.org Abstract. The new book

More information

Cancer incidence near municipal solid waste incinerators in Great Britain. COC statement COC/00/S1 - March 2000

Cancer incidence near municipal solid waste incinerators in Great Britain. COC statement COC/00/S1 - March 2000 Cancer incidence near municipal solid waste incinerators in Great Britain COC statement COC/00/S1 - March 2000 Introduction 1. There have been very few epidemiological studies published which investigated

More information

Global surveillance of cancer survival

Global surveillance of cancer survival Global surveillance of cancer survival Claudia Allemani Helena Carreira Rhea Harewood Devon Spika Xiao-Si Wang Finian Bannon Jane Ahn Loraine Marrett Donna Turner Thomas C Tucker Hannah K Weir CONCORD

More information

C aring for patients with interstitial lung disease is an

C aring for patients with interstitial lung disease is an 980 INTERSTITIAL LUNG DISEASE Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK J Gribbin, R B Hubbard, I Le Jeune, C J P Smith, J West, L J Tata... See end of article

More information

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study Michael Wallington*, Emma B Saxon*, Martine Bomb, Rebecca Smittenaar,

More information

Downloaded from:

Downloaded from: Woods, LM; Rachet, B; O Connell, D; Lawrence, G; Coleman, MP (2016) Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South

More information

Index. Springer International Publishing Switzerland 2017 T.J. Cleophas, A.H. Zwinderman, Modern Meta-Analysis, DOI /

Index. Springer International Publishing Switzerland 2017 T.J. Cleophas, A.H. Zwinderman, Modern Meta-Analysis, DOI / Index A Adjusted Heterogeneity without Overdispersion, 63 Agenda-driven bias, 40 Agenda-Driven Meta-Analyses, 306 307 Alternative Methods for diagnostic meta-analyses, 133 Antihypertensive effect of potassium,

More information

Trends in cancer incidence in South East England Henrik Møller and all staff at the Thames Cancer Registry, King s College London

Trends in cancer incidence in South East England Henrik Møller and all staff at the Thames Cancer Registry, King s College London Trends in cancer incidence in South East England 1960-2009 Henrik Møller and all staff at the Thames Cancer Registry, King s College London 1 2 3 Analysts Vicki Coupland Ruth Jack Margreet Lüchtenborg

More information

Cancer survival and prevalence in Tasmania

Cancer survival and prevalence in Tasmania Cancer survival and prevalence in Tasmania 1978-2008 Cancer survival and prevalence in Tasmania 1978-2008 Tasmanian Cancer Registry University of Tasmania Menzies Research Institute Tasmania 17 Liverpool

More information

Urological cancers why we need to change. Stakeholder workshop 14 March 2013

Urological cancers why we need to change. Stakeholder workshop 14 March 2013 Urological cancers why we need to change Stakeholder workshop 14 March 2013 Introduction and welcome Today s event aims to cover: 1. Background, clinical evidence and London Cancer s recommendations Q&As

More information

ethnicity recording in primary care

ethnicity recording in primary care ethnicity recording in primary care Multiple imputation of missing data in ethnicity recording using The Health Improvement Network database Tra Pham 1 PhD Supervisors: Dr Irene Petersen 1, Prof James

More information

Chiara Di Girolamo 1,2*, Sarah Walters 1, Sara Benitez Majano 1, Bernard Rachet 1, Michel P. Coleman 1, Edmund Njeru Njagi 1 and Melanie Morris 1

Chiara Di Girolamo 1,2*, Sarah Walters 1, Sara Benitez Majano 1, Bernard Rachet 1, Michel P. Coleman 1, Edmund Njeru Njagi 1 and Melanie Morris 1 Di Girolamo et al. BMC Cancer (2018) 18:492 https://doi.org/10.1186/s12885-018-4417-3 RESEARCH ARTICLE Open Access Characteristics of patients with missing information on stage: a population-based study

More information

PRACTICAL STATISTICS FOR MEDICAL RESEARCH

PRACTICAL STATISTICS FOR MEDICAL RESEARCH PRACTICAL STATISTICS FOR MEDICAL RESEARCH Douglas G. Altman Head of Medical Statistical Laboratory Imperial Cancer Research Fund London CHAPMAN & HALL/CRC Boca Raton London New York Washington, D.C. Contents

More information

An example of a systematic review and meta-analysis

An example of a systematic review and meta-analysis An example of a systematic review and meta-analysis Sattar N et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010; 375: 735-742. Search strategy

More information

Chapter 4: High Blood Pressure

Chapter 4: High Blood Pressure Key points Chapter 4: High blood pressure is common in New Zealand and is an important contributing factor to heart disease and stroke. Actual blood pressure measurements were not carried out as part of

More information

Contour enhanced funnel plots for meta-analysis

Contour enhanced funnel plots for meta-analysis Contour enhanced funnel plots for meta-analysis Tom Palmer 1, Jaime Peters 2, Alex Sutton 3, Santiago Moreno 3 1. MRC Centre for Causal Analyses in Translational Epidemiology, Department of Social Medicine,

More information

National Cancer Survivorship Initiative

National Cancer Survivorship Initiative National Cancer Survivorship Initiative National Cancer PROMS Programme DH PROMs & Cancer Policy Teams Originally. NHS England Now. ADAM GLASER Background Increasing prevalence of cancer increase of 3.2%

More information

WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK

WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK Pooled analysis of all-cause and influenza-attributable mortality from 21 European countries participating in the EuroMOMO network

More information

The Meta on Meta-Analysis. Presented by Endia J. Lindo, Ph.D. University of North Texas

The Meta on Meta-Analysis. Presented by Endia J. Lindo, Ph.D. University of North Texas The Meta on Meta-Analysis Presented by Endia J. Lindo, Ph.D. University of North Texas Meta-Analysis What is it? Why use it? How to do it? Challenges and benefits? Current trends? What is meta-analysis?

More information

February 14, 2001 ! OUTLINE

February 14, 2001 ! OUTLINE February 14, 2001! OUTLINE ASSESSING THE GENERALIZABILITY OF THE RESULTS OF - Define the problem MULTINATIONAL TRIALS FOR INDIVIDUAL COUNTRIES PARTICIPATING IN THE TRIAL - Common Approaches to the problem

More information

Use of GEEs in STATA

Use of GEEs in STATA Use of GEEs in STATA 1. When generalised estimating equations are used and example 2. Stata commands and options for GEEs 3. Results from Stata (and SAS!) 4. Another use of GEEs Use of GEEs GEEs are one

More information

Oncology Drug Development

Oncology Drug Development Oncology Drug Development Advantages and challenges of using stratified clinical studies Simon J Hollingsworth The 18th Anti-Tumour Drug Development Forum 21 February Japan Stratified Medicine In The Clinic

More information

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study Sara Benitez Majano, Chiara Di Girolamo, Bernard Rachet, Camille Maringe, Marianne

More information

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study Sara Benitez Majano, Chiara Di Girolamo, Bernard Rachet, Camille Maringe, Marianne

More information

Knowledge Discovery and Data Mining. Testing. Performance Measures. Notes. Lecture 15 - ROC, AUC & Lift. Tom Kelsey. Notes

Knowledge Discovery and Data Mining. Testing. Performance Measures. Notes. Lecture 15 - ROC, AUC & Lift. Tom Kelsey. Notes Knowledge Discovery and Data Mining Lecture 15 - ROC, AUC & Lift Tom Kelsey School of Computer Science University of St Andrews http://tom.home.cs.st-andrews.ac.uk twk@st-andrews.ac.uk Tom Kelsey ID5059-17-AUC

More information

THE ANALYSES TO DETERMINE THE RELATIONSHIP BETWEEN SLEEPING PROBLEMS AND THE HEALTH OUTCOMES OF THE ELDER PEOPLE

THE ANALYSES TO DETERMINE THE RELATIONSHIP BETWEEN SLEEPING PROBLEMS AND THE HEALTH OUTCOMES OF THE ELDER PEOPLE THE ANALYSES TO DETERMINE THE RELATIONSHIP BETWEEN SLEEPING PROBLEMS AND THE HEALTH OUTCOMES OF THE ELDER PEOPLE A study submitted in partial fulfillment of the requirements for the degree of Master of

More information

Title: What is the optimal period for measuring hand-hygiene compliance: are longer. Sheldon Stone UCL Medical School, University College London

Title: What is the optimal period for measuring hand-hygiene compliance: are longer. Sheldon Stone UCL Medical School, University College London Title: What is the optimal period for measuring hand-hygiene compliance: are longer periods better than 20 minute periods? Authors: Sheldon Stone UCL Medical School, University College London Chris Fuller,

More information

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women with Type 2 Diabetes.

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women with Type 2 Diabetes. Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women with Type 2 Diabetes. Wu, J. W., Azoulay, L., Majdan, A., Boivin, J. F., Pollak, M., and Suissa, S. Journal of Clinical

More information

Appendix. Lifetime extrapolation of data from the randomised controlled DiGEM trial

Appendix. Lifetime extrapolation of data from the randomised controlled DiGEM trial Appendix Lifetime extrapolation of data from the randomised controlled DiGEM trial Judit Simon, Alastair Gray, Philip Clarke, Alisha Wade, Andrew Neil, Andrew Farmer on behalf of the Diabetes Glycaemic

More information

IJC International Journal of Cancer

IJC International Journal of Cancer IJC International Journal of Cancer Cure of cancer for seven cancer sites in the Flemish Region Geert Silversmit 1, David Jegou 1, Evelien Vaes 1, Elke Van Hoof 2, Els Goetghebeur 3 and Liesbet Van Eycken

More information

SAC 17 Queen Mary University of London

SAC 17 Queen Mary University of London East Anglia Region of the RSC Analytical Division National Schools Analyst Competition Regional Heat Queen Mary University of London, Friday 24 th February 2017 School of Biological and Chemical Sciences,

More information

CHAPTER 10 CANCER REPORT. Angela Webster Germaine Wong

CHAPTER 10 CANCER REPORT. Angela Webster Germaine Wong CHAPTER 10 Angela Webster Germaine Wong ANZDATA Registry 2008 Report This year the cancer report contains results of a new ANZDATA analysis on survival after cancer diagnosis, and also shows how ANZDATA

More information

A multi-stakeholder partnership initiative. 10 February 2012

A multi-stakeholder partnership initiative. 10 February 2012 A multi-stakeholder partnership initiative 10 February 2012 1 History 39 recommendations on stakeholder actions and public policies:» 8 addressing regulatory barriers in rare cancer care» 11 addressing

More information

Network Meta-Analyses of Antipsychotics for Schizophrenia: Clinical Implications

Network Meta-Analyses of Antipsychotics for Schizophrenia: Clinical Implications Network Meta-Analyses of Antipsychotics for Schizophrenia: Clinical Implications JOHN M. DAVIS, MD Professor of Psychiatry University of Illinois at Chicago Chicago, Illinois and STEFAN LEUCHT, MD Klinik

More information

GUIDELINE COMPARATORS & COMPARISONS:

GUIDELINE COMPARATORS & COMPARISONS: GUIDELINE COMPARATORS & COMPARISONS: Direct and indirect comparisons Adapted version (2015) based on COMPARATORS & COMPARISONS: Direct and indirect comparisons - February 2013 The primary objective of

More information

Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham

Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham Improvement Analytics Unit September 2018 Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham Therese Lloyd, Richard Brine, Rachel Pearson, Martin

More information

The impact of cancer waiting times on survival for selected cancers in England,

The impact of cancer waiting times on survival for selected cancers in England, The impact of cancer waiting times on survival for selected cancers in England, 2009-2013 Chiara Di Girolamo 1, Carolynn Gildea 2, Melanie Morris 1, Sara Benitez Majano 1, Sarah Walters 1 1 Cancer Policy

More information

PAH - Sources and Measurement Mike Woodfield - AEAT

PAH - Sources and Measurement Mike Woodfield - AEAT PAH - Sources and Measurement Mike Woodfield - AEAT The Background (1) PAH in Ambient include substances known to produce cancer; World Health Organisation considers the risk to human health from ambient

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland

More information

A Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers

A Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwg278 PRACTICE OF EPIDEMIOLOGY

More information

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer

The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer The 2003 Council Recommendation on Cancer Screening and the European Initiative on Breast Cancer Conference "Putting Science into Standards" Ispra 20-21 October 2015 Michael Hübel, Head of Unit - Programme

More information

Cochrane Pregnancy and Childbirth Group Methodological Guidelines

Cochrane Pregnancy and Childbirth Group Methodological Guidelines Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews

More information

Definitions of substandard and falsified medical products

Definitions of substandard and falsified medical products EXECUTIVE SUMMARY EXECUTIVE SUMMARY Introduction In 2015, the World Health Organization (WHO) Member State mechanism commissioned a study on the public health and socioeconomic impact of substandard and

More information

RAG Rating Indicator Values

RAG Rating Indicator Values Technical Guide RAG Rating Indicator Values Introduction This document sets out Public Health England s standard approach to the use of RAG ratings for indicator values in relation to comparator or benchmark

More information

Survival Rates of Childhood Cancer Patients in Osaka, Japan

Survival Rates of Childhood Cancer Patients in Osaka, Japan Jpn J Clin Oncol 2004;34(1)50 54 Epidemiology Note Survival Rates of Childhood Cancer Patients in Osaka, Japan Wakiko Ajiki, Hideaki Tsukuma and Akira Oshima Department of Cancer Control and Statistics,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.

More information

Title :The Epidemiology of Salmonella Infections in the Baltimore Metropolitan area.

Title :The Epidemiology of Salmonella Infections in the Baltimore Metropolitan area. Title :The Epidemiology of Salmonella Infections in the Baltimore Metropolitan area. Student: Joanne Caruth Preceptor: Pat Ryan Salmonellosis Infection with Salmonella bacteria Over 2,000 different serotypes

More information

Changes in Dementia Incidence, Prevalence, Severity and Mortality

Changes in Dementia Incidence, Prevalence, Severity and Mortality Changes in Dementia Incidence, Prevalence, Severity and Mortality Estimating future demand across the Dementia pathway A support pack for commissioning Dementia services NHS Dudley Clinical Commissioning

More information

Haemato-oncology Clinical Forum. 20 th June 2013

Haemato-oncology Clinical Forum. 20 th June 2013 Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland

More information

Integrated Impact Assessment Report for Service Specifications

Integrated Impact Assessment Report for Service Specifications Integrated Impact Assessment Report for Service Specifications Service Specification Reference Service Specification Accountable Commissioner B14/S/a Urological cancers Specialised kidney, bladder and

More information